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ABSTRACT: 
BACKGROUND: The value of salivary cortisol measurement to study stress-related adrenal 
response is controversial. The study aim was to assess the role of salivary cortisol measurement to 
detect time-related changes of adrenal response in critically ill patients. 
PATIENTS AND METHODS: Patients with organ failure, sepsis or trauma were prospectively 
recruited in the Emergency Department. Serum and salivary cortisol were measured at baseline (T0) 
and after 48 hours (T48). In 33 patients ACTH test was also done. 
RESULTS: Fifty-five patients were studied and classified as septic (22) or non-septic (33). We 
found a significant correlation between serum and salivary cortisol at T0 and T48. No patient had 
baseline serum cortisol < 276 nmol/L and salivary cortisol significantly decreased at T48 in almost 
all patients. A delta serum cortisol < 250 nmol/L after ACTH was found in only 4 patients who 
showed elevated baseline cortisol levels. 
CONCLUSION: We found that reduced baseline and post-ACTH cortisol levels are uncommon in 
our samples. In patients able to provide adequate saliva samples, salivary cortisol may be used to 
check the degree of stress-induced response and appears as a suitable tool for multiple 
measurements over time.   
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INTRODUCTION 
The physiological response to acute stress and life-threatening conditions includes an increased 
activity of the adrenal glands resulting in raised cortisol levels, which are needed to support vital 
functions and restore homeostasis (fight or flight response) [1]. Studies pointed out that inadequate 
cortisol response to stressful stimuli might be associated with increased risk of mortality [2,3]. 
Therefore, the concept of "critical illness-related corticosteroid insufficiency" (CIRCI) has been 
introduced to define a condition characterized by baseline cortisol levels < 276 nmol/L or delta 
cortisol (difference between peak and baseline cortisol levels during a 250 μg ACTH stimulation 
test) < 250 nmol/L [4], although these criteria are still debated [5]. More recently, studies 
challenged this concept showing that high cortisol levels in critically ill patients were actually 
associated with increased risk of mortality [6,7,8]. In this area of uncertainty there is a further 
difficulty due to methodological issues related to cortisol measurement, because in acutely ill 
patients albumin and cortisol-binding protein (CBG) levels may be altered and a standardized 
method to evaluate free plasma cortisol is not currently available [9]. Although some evidence 
suggest that salivary cortisol could be a surrogate marker for serum free cortisol [10,11,12,13,14] 
data are lacking to support its routine use in critically ill patients [4].  
Therefore, the aim of the present study was to determine cortisol levels in a population of critically 
ill patients in the first 48 hours after their admission in the Emergency Room, and to test if salivary 
cortisol measurement may add useful information to serum cortisol measurement.  
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PATIENTS AND METHODS 
Patients 
Patients were prospectively recruited in the Emergency Department of the San Giovanni Bosco 
Hospital (Turin), among those subsequently admitted in the Emergency Medical Unit, from 
September 2016 to December 2017. The study was conducted in accordance with the ethical 
guidelines of the 2003 (Declaration of Helsinki) and approved by the San Giovanni Bosco Hospital 
Ethics Committee. Written consent was obtained from patients and/or their designated family 
members. 
Critically ill patients affected by a wide range of illness, and displaying single or multiple organ 
failure, were enrolled on the basis of the following inclusion and exclusion criteria. Inclusion 
criteria were: one or more of the followings: acute respiratory insufficiency, cardiovascular 
insufficiency or other organ insufficiency, sepsis or septic shock, acute pancreatitis, trauma (no 
brain injury), post-surgical complications. Diagnosis of sepsis and septic shock were based on the 
criteria established by the American College of Chest Physicians and the Society of Critical Care 
Medicine [15]. Exclusion criteria were: age <18 years, ongoing mechanical ventilation, current or 
recent glucocorticoid therapy, neoplastic disease, intake of drugs known to influence 
glucocorticoids secretion (etomidate, ketoconazole, estrogen, phenytoin, phenobarbital and 
rifampicin), known pituitary, adrenal or liver disease, HIV or mycobacterial infection, pregnancy, 
immunosuppressive therapy. Patients were enrolled at the Emergency Room (ER) before admission. 
Assessment of the hypothalamic pituitary axis (HPA) was done at patient enrollment (T0) and after 
48 hours (T48), in concomitance with physical exam and routine biochemical evaluation. The 
severity of illness was assessed by the Simplified Acute Physiology Score (SAPS) II and qSOFA 
score [16]. The life status (death/alive) of the patients was checked at T48 and at day 28 after 
admission. 
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Methods 
Within 24 hours from admission, blood and saliva samples were concomitantly obtained from all 
patients (baseline, T0). Blood and saliva samples were also taken after 48 hours (T48) from the first 
samples. Saliva samples were obtained by giving patients three cotton swabs to chew for 2 minutes. 
The cotton swabs were then placed in a saliva-collecting device (Salivette® – Sarstedt, Numbrecht, 
Germany) and centrifuged at 3000 rpm for 15 min. The cotton swabs were removed, and the 
samples were frozen at –20 °C until assayed. At baseline, salivary cortisol and serum cortisol were 
measured. At T48, salivary and serum cortisol were measured. Routine laboratory measurements 
included arterial blood gases, lactate, C-reactive protein, procalcitonin, blood electrolytes, total 
blood cells count, liver function tests, creatinine, and albumin. 
Immediately after baseline sampling, 33 patients underwent a short corticotropin stimulation test. 
This test was performed between h.08.00 and 9.00 a.m. by intravenous administration of 250 μg of 
synthetic corticotropin (tetra-cosactide-hexa-acetate, Synacthen, Novartis Pharma, Basel, 
Switzerland). Blood and salivary samples were taken immediately before and 60 minutes after 
ACTH injection. The difference between serum cortisol at 60 min and at baseline (delta cortisol) 
was calculated to assess the response to ACTH stimulation. A subnormal response to ACTH 
stimulation was defined by a delta cortisol < 250 nmol/L [4].  
 
Laboratory analyses 
Salivary cortisol concentrations were determined using an ELISA kit (Enzyme-Linked 
ImmunoSorbent Assay), obtained from DGR instruments GmbH (Germany). The assay sensitivity 
was 1 nmol/L. As to specificity, this cortisol assay does not show cross-reaction with cortisone, 
deoxycorticosterone, 11-deoxycorticortisol, estradiol, testosterone, and 17-hydroxyprogesterone, 
while it cross-reacts 29% with corticosterone and 3% with cortisone. The reference range for our 
laboratory was 3–40 nmol/L, for both sexes.  
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Serum cortisol was measured by chemiluminescent immunometric assay (Immulite 1000, Siemens 
Medical Solutions Diagnostics, Los Angeles, CA, USA). The detection limit was 5 nmol/L. The 
reference range was 250-690 nmol/L.  
 
Statistical analyses  
All statistical analyses were performed with STATA statistical software. Categorical data were 
presented as rates and proportions, continuous data as medians and ranges. Wilcoxon rank-sum test 
was used for analysis of continuous variables and Chi-Square Test was used for nominal 
or ordinal explanatory and response variables. P values of less than 0.05 were considered to indicate 
statistical significance.  
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RESULTS  
A total of 71 patients were eligible for inclusion in the study. One patient was excluded because he 
received a steroid pulse before admission and 15 patients were excluded because the amount of 
saliva samples was insufficient for the assay (Figure 1).  
Baseline characteristics of the 55 evaluated patients are reported in Table 1.  
 
 
Table 1. Baseline features of the overall samples and the two groups classified according to 
presence of sepsis. 
Characteristics 
Overall 
(n=55) 
Sepsis  
(n=22) 
No Sepsis 
(n=33) 
p 
Gender – N. (%) 
Male 
Female 
36 (65%) 
19 (35%) 
14 (63.6%) 
8 (36.4%) 
22 (66.7%) 
11 (33.3%) 
 
0.86 
Age at admission – yr 
Median [range] 70 [17-87] 65 [42-87] 71 [17-84] 
 
0.49 
BMI – kg/m2 
Median  
[range] 
 
26.8 
[16.3-48.9] 
 
26.0 
[16.3-46.8] 
 
27.5 
[18.5-48.9] 
 
0.10 
Systolic Blood Pressure – 
(mmHg) 
Median [range] 
 
130 [70-230] 
 
125 [70-230] 
 
136 [87-230] 
 
0.07 
Diastolic Blood Pressure – 
(mmHg) 
Median [range] 
 
70 [35-130] 
 
70 [40-130] 
 
70 [35-120] 
 
0.47 
Heart rate – (bpm) 
Median [range] 
 
90 [65-160] 
 
99 [70-130] 
 
86 [65-160] 
 
0.32 
Respiratory rate – (bpm) 
Median [range] 
 
26 [12-46] 
 
24 [12-46] 
 
27 [14-44] 
 
0.93 
SO2 – (%) 
Median [range] 
 
94 [70-99] 
 
96 [70-99] 
 
94 [72-99] 
 
0.91 
Temperature – (°C) 
Median [range] 
 
37 [36-41] 
 
37.4 [36-41] 
 
37 [36-39] 
 
0.01 
Lactate – (mmol/L) 
Median [range] 
 
1.4 [0.1-8.3] 
 
1.5 [0.5-7.7] 
 
1.4 [0.1-8.3] 
 
0.80 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 8 
Protein - (g/dL) 
Median [range] 6.1 [4.3-7.9] 5.5 [4.3-7.8] 6.3 [5.5-7.1] 
 
0.02 
Albumin – (g/dL) 
Median [range] 3.1 [0.5-4.3] 2.8 [1.5-4.3] 3.4 [0.5-4.3] 
 
0.02 
Hospitalization – (day) 
Median [range] 
 
11 [4-38] 
 
11 [4-24] 
 
10.5 [4-38] 
 
0.73 
Hospitalization in ED– (day) 
Median [range] 
6 [1-21] 6 [2-15] 5 [1-10] 
 
 
0.76 
 
BMI=body mass index; SBP=systolic blood pressure; DBP=diastolic blood pressure; SO2=hemoglobin oxygen saturation. 
 
The patient group had different medical emergencies; the most frequent diagnosis at presentation 
was acute respiratory failure (50.9%) followed by acute heart failure (16.4%), suspected infections 
(16.4%), trauma (7.3%), acute pancreatitis (3.6%), septic shock (3.6%), or any organ failure (1.8%). 
A broad spectrum of comorbidities affected our patients, such as arterial hypertension (56.4%), 
diabetes mellitus (30.9%), coronary artery disease (25.4%), heart failure (21.8%), chronic kidney 
disease (20%), chronic obstructive pulmonary disease (20%), arrhythmia (14.5%), vascular disease 
(7.3%), liver disease (3.6%), pulmonary hypertension (3.6%), peripheral arterial disease (1.8%), 
peptic ulcer (1.8%), autoimmune diseases (1.8%). We divided our population in two subgroups 
based on the presence of sepsis, which was diagnosed in 22 out of 55 patients. Baseline 
characteristics of the two subgroups of patients are reported in Table 1.  
In the overall sample, the median SAPS II score was 37 (16-77), without difference between the 
two groups (sepsis group, 36, 16-61 vs. no-sepsis group, 37, 17-77, p = 0.76). In the sepsis group, 
the median qSOFA was 1 [range 0-2]. 
Median serum cortisol concentration at T0 in the overall sample was 819 nmol/L (292-2458 
nmol/L) and median salivary cortisol concentration at T0 was 41 nmol/L (range 1-347 nmol/L). No 
patient had baseline serum cortisol < 276 nmol/L. Median serum cortisol concentration at T48 was 
634 nmol/L (287-1826 nmol/L) and median salivary cortisol concentration at T48 was 13 nmol/L 
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 9 
(range 1-253 nmol/L). We found a significant correlation between serum and salivary cortisol 
concentrations measured at T0 (r 0.84, p <0.001), and T48 (r 0.81, p <0.001).  
We found a statistically significant difference between salivary cortisol concentrations at T0 vs. T48 
(p<0.001) (Figure 2).  
In the sepsis group, salivary cortisol concentration decreased from 60 nmol/L (range 1-347 nmol/L) 
at T0 to 21 nmol/L (1-135 nmol/L) at T48 (p<0.001). In the no-sepsis group, salivary cortisol 
concentration decreased from 39 nmol/L (range 1-221 nmol/L) at T0 to 11 nmol (range 1-253 
nmol/L) at T48 (p=0.022) (Figure 3). We also compared salivary cortisol concentrations between 
the two groups and we found a statistically significant difference in salivary cortisol values at T48 
(p=0.03), while no significant difference was apparent at T0 (Figure 3). 
We did not find any significant correlation between serum or salivary cortisol and SAPS values. 
For logistic reasons (i.e. night-time admission), the ACTH stimulation test was performed in 33 
patients. The serum cortisol value at 60 min was 1534 nmol/L (510-2676 nmol/L), and the salivary 
cortisol was 156 nmol/L (range 17-1528 nmol/L); with a significant correlation between them (r 
0.49, p <0.01). The delta serum cortisol was 588 nmol/L (range -110 – 1432 nmol/L) and the 
percentage of the increase was 79% (range -6 – 393%). The delta salivary cortisol was 113 nmol/L 
(range -54 – 1308 nmol/L) and the percentage of the increase was 191% (range -16 –1672%) 
(Figure 4).  
We found a delta serum cortisol < 250 nmol/L in 4 out 33 cases (12.1%). These patients had 
exceedingly high serum cortisol levels at T0 (1581; 1545; 2458; 1975 nmol/L, respectively), high 
values of SAPS (39, 58, 61, 77, respectively), increased lactate concentrations, and sepsis was 
diagnosed in three of them. The response of salivary cortisol to Synacthen was also blunted (percent 
of increment 37%, -7%, -16%, 18%, respectively). 
Mortality rate was 1/55 patients at T48, and 5/55 patients at day 28. Due to the low mortality rate 
observed in our cohort, we did not analyze the correlation with cortisol levels.  
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DISCUSSION 
In the last 30 years, there was a fierce debate on the existence of a correlation between mortality 
and cortisol levels in critically ill patients, particularly when levels are at the lower end of the 
spectrum, configuring the so-called CIRCI [2,4,5]
 
, or when they are exceedingly high [6,7,8]. In 
both cases, the assessment of serum cortisol is not completely reliable, due to the decrease of CBG 
and albumin in critically ill patients [17]. As a matter of fact, 80-90% of serum cortisol is bound to 
CBG, 5-10% is bound to albumin, while only 5% is unbound [18]. At the same time, the laboratory 
evaluation of free serum cortisol is difficult, requiring special equipment. On the contrary, salivary 
cortisol measurement is cheap, noninvasive and unaffected by variations in CBG or albumin. 
The recent guidelines on CIRCI diagnosis and management suggest against the use of salivary 
cortisol for diagnostic purposes, although this is a conditional recommendation with a very low 
quality of evidence [5]. One of the objections raised in the guidelines concerns the difficulty in 
collecting adequate salivary samples in critically ill patients, often intubated and dehydrated. 
Studies report that it was impossible to analyze about 30% of the salivary samples, due to 
insufficient saliva, or blood contamination [13,14]; conversely, in one study [12] only 5.5% of 
enrolled patients had inadequate saliva samples. In the present study, we confirm that collecting 
saliva is not an easy task in the ER, since 21.4% of our patients were excluded due to a small 
volume of saliva collected. This discrepancy among the studies is probably due to different types of 
population analyzed, with variable grade of illness severity and number of intubated patients. 
Whether the use of different saliva-collecting devices (for example infant-swab-devices) could 
ameliorate the success of obtaining adequate saliva samples in critically ill patients deserves future 
investigation. 
Many studies supported the use of salivary cortisol as a surrogate for free cortisol in patients with 
critical illness, because it is as reliable as serum free cortisol, but not affected by the high cost and 
low availability of equilibrium dialysis, needed to determine free serum cortisol [12,13,14].  
This concept was confirmed by our study, where we found a significant correlation between serum 
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and salivary cortisol measurements. The strong correlation between salivary cortisol and total serum 
cortisol levels has been demonstrated not only at baseline, as in previous studies [12,13,14] but also 
after 48 hours of hospitalization.  This is a new element introduced by our research reporting a 
statistically significant difference between T0 and T48 salivary cortisol concentrations in the whole 
group, and in the two subgroups of septic and non-septic patients. We showed that salivary cortisol 
decreases after 48 hours, a finding that likely reflects the shutting down of adrenal hyperactivity. 
Interestingly, the change in salivary cortisol seems to be more sensitive and precocious that serum 
cortisol, which was less modified over time. We observed a similar pattern during ACTH 
stimulation test. There are scanty data on the response of salivary cortisol to Synacthen and a 
universally accepted cut-off is not available [12, 19, 20], due to the great heterogeneity of the assays 
used to measure salivary cortisol between different studies.  
This is the first study with a direct comparison between septic and non-septic patients, classified on 
the basis of the recent diagnostic criteria of sepsis [16].  In our study, we did not find any 
correlation between the severity of illness and salivary or serum cortisol levels. Therefore, our data 
do not seem to support the hypothesis that salivary cortisol increases in parallel to the severity of 
stress [13]. However, we may disclose the fact that the severity of illness and sepsis was moderate 
in many patients. Moreover, we found a significantly higher value of salivary cortisol at T48 in the 
group of septic patients, which may reflect a more persistent activation of the HPA axis in this 
condition. We also found a correlation between serum and salivary cortisol at 60 min of the ACTH 
stimulation test. The role of salivary cortisol as surrogate for serum free cortisol in dynamic testing 
of adrenocortical function has been previously investigated [12, 19, 20], and our findings further 
support the use of salivary cortisol in this setting. 
We did not find any evidence of CIRCI in our cohort, since no patient had baseline serum cortisol 
<276 nmol/L, and a delta serum cortisol < 250 nmol/L after ACTH stimulation was observed in 
only 12% of cases. However, baseline cortisol levels were very high in such patients, suggesting 
that the reduced delta cortisol value may reflect a maximally stimulated HPA axis more than 
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adrenal insufficiency. Interestingly, the 4 patients with a delta serum cortisol < 250 nmol/L after 
ACTH stimulation had concomitantly blunted salivary cortisol response. 
We acknowledge the limitations of the study, including a small sample size and the heterogeneity of 
the population. Moreover, it could be argued that the low severity of illness in our patients, 
confirmed by a low mortality rate, is also a limitation.  
To conclude, proven that patients are able to collaborate and provide adequate saliva samples, 
salivary cortisol may be used to check the degree of stress-induced activation of the HPA axis, and 
appears as a suitable tool for multiple measurements over time.  
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ABSTRACT: 
BACKGROUND: The value of salivary cortisol measurement to study stress-related adrenal 
response is controversial. The study aim was to assess the role of salivary cortisol measurement to 
detect time-related changes of adrenal response in critically ill patients. 
PATIENTS AND METHODS: Patients with organ failure, sepsis or trauma were prospectively 
recruited in the Emergency Department. Serum and salivary cortisol were measured at baseline (T0) 
and after 48 hours (T48). In 33 patients ACTH test was also done. 
RESULTS: Fifty-five patients were studied and classified as septic (22) or non-septic (33). We 
found a significant correlation between serum and salivary cortisol at T0 and T48. No patient had 
baseline serum cortisol < 276 nmol/L and salivary cortisol significantly decreased at T48 in almost 
all patients. A delta serum cortisol < 250 nmol/L after ACTH was found in only 4 patients who 
showed elevated baseline cortisol levels. 
CONCLUSION: We found that reduced baseline and post-ACTH cortisol levels are uncommon in 
our samples. In patients able to provide adequate saliva samples, salivary cortisol may be used to 
check the degree of stress-induced response and appears as a suitable tool for multiple 
measurements over time.   
 3 
INTRODUCTION 
The physiological response to acute stress and life-threatening conditions includes an increased 
activity of the adrenal glands resulting in raised cortisol levels, which are needed to support vital 
functions and restore homeostasis (fight or flight response) [1]. Studies pointed out that inadequate 
cortisol response to stressful stimuli might be associated with increased risk of mortality [2,3]. 
Therefore, the concept of "critical illness-related corticosteroid insufficiency" (CIRCI) has been 
introduced to define a condition characterized by baseline cortisol levels < 276 nmol/L or delta 
cortisol (difference between peak and baseline cortisol levels during a 250 μg ACTH stimulation 
test) < 250 nmol/L [4], although these criteria are still debated [5]. More recently, studies 
challenged this concept showing that high cortisol levels in critically ill patients were actually 
associated with increased risk of mortality [6,7,8]. In this area of uncertainty there is a further 
difficulty due to methodological issues related to cortisol measurement, because in acutely ill 
patients albumin and cortisol-binding protein (CBG) levels may be altered and a standardized 
method to evaluate free plasma cortisol is not currently available [9]. Although some evidence 
suggest that salivary cortisol could be a surrogate marker for serum free cortisol [10,11,12,13,14] 
data are lacking to support its routine use in critically ill patients [4].  
Therefore, the aim of the present study was to determine cortisol levels in a population of critically 
ill patients in the first 48 hours after their admission in the Emergency Room, and to test if salivary 
cortisol measurement may add useful information to serum cortisol measurement.  
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PATIENTS AND METHODS 
Patients 
Patients were prospectively recruited in the Emergency Department of the San Giovanni Bosco 
Hospital (Turin), among those subsequently admitted in the Emergency Medical Unit, from 
September 2016 to December 2017. The study was conducted in accordance with the ethical 
guidelines of the 2003 (Declaration of Helsinki) and approved by the San Giovanni Bosco Hospital 
Ethics Committee. Written consent was obtained from patients and/or their designated family 
members. 
Critically ill patients affected by a wide range of illness, and displaying single or multiple organ 
failure, were enrolled on the basis of the following inclusion and exclusion criteria. Inclusion 
criteria were: one or more of the followings: acute respiratory insufficiency, cardiovascular 
insufficiency or other organ insufficiency, sepsis or septic shock, acute pancreatitis, trauma (no 
brain injury), post-surgical complications. Diagnosis of sepsis and septic shock were based on the 
criteria established by the American College of Chest Physicians and the Society of Critical Care 
Medicine [15]. Exclusion criteria were: age <18 years, ongoing mechanical ventilation, current or 
recent glucocorticoid therapy, neoplastic disease, intake of drugs known to influence 
glucocorticoids secretion (etomidate, ketoconazole, estrogen, phenytoin, phenobarbital and 
rifampicin), known pituitary, adrenal or liver disease, HIV or mycobacterial infection, pregnancy, 
immunosuppressive therapy. Patients were enrolled at the Emergency Room (ER) before admission. 
Assessment of the hypothalamic pituitary axis (HPA) was done at patient enrollment (T0) and after 
48 hours (T48), in concomitance with physical exam and routine biochemical evaluation. The 
severity of illness was assessed by the Simplified Acute Physiology Score (SAPS) II and qSOFA 
score [16]. The life status (death/alive) of the patients was checked at T48 and at day 28 after 
admission. 
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Methods 
Within 24 hours from admission, blood and saliva samples were concomitantly obtained from all 
patients (baseline, T0). Blood and saliva samples were also taken after 48 hours (T48) from the first 
samples. Saliva samples were obtained by giving patients three cotton swabs to chew for 2 minutes. 
The cotton swabs were then placed in a saliva-collecting device (Salivette® – Sarstedt, Numbrecht, 
Germany) and centrifuged at 3000 rpm for 15 min. The cotton swabs were removed, and the 
samples were frozen at –20 °C until assayed. At baseline, salivary cortisol and serum cortisol were 
measured. At T48, salivary and serum cortisol were measured. Routine laboratory measurements 
included arterial blood gases, lactate, C-reactive protein, procalcitonin, blood electrolytes, total 
blood cells count, liver function tests, creatinine, and albumin. 
Immediately after baseline sampling, 33 patients underwent a short corticotropin stimulation test. 
This test was performed between h.08.00 and 9.00 a.m. by intravenous administration of 250 μg of 
synthetic corticotropin (tetra-cosactide-hexa-acetate, Synacthen, Novartis Pharma, Basel, 
Switzerland). Blood and salivary samples were taken immediately before and 60 minutes after 
ACTH injection. The difference between serum cortisol at 60 min and at baseline (delta cortisol) 
was calculated to assess the response to ACTH stimulation. A subnormal response to ACTH 
stimulation was defined by a delta cortisol < 250 nmol/L [4].  
 
Laboratory analyses 
Salivary cortisol concentrations were determined using an ELISA kit (Enzyme-Linked 
ImmunoSorbent Assay), obtained from DGR instruments GmbH (Germany). The assay sensitivity 
was 1 nmol/L. As to specificity, this cortisol assay does not show cross-reaction with cortisone, 
deoxycorticosterone, 11-deoxycorticortisol, estradiol, testosterone, and 17-hydroxyprogesterone, 
while it cross-reacts 29% with corticosterone and 3% with cortisone. The reference range for our 
laboratory was 3–40 nmol/L, for both sexes.  
 6 
Serum cortisol was measured by chemiluminescent immunometric assay (Immulite 1000, Siemens 
Medical Solutions Diagnostics, Los Angeles, CA, USA). The detection limit was 5 nmol/L. The 
reference range was 250-690 nmol/L.  
 
Statistical analyses  
All statistical analyses were performed with STATA statistical software. Categorical data were 
presented as rates and proportions, continuous data as medians and ranges. Wilcoxon rank-sum test 
was used for analysis of continuous variables and Chi-Square Test was used for nominal 
or ordinal explanatory and response variables. P values of less than 0.05 were considered to indicate 
statistical significance.  
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RESULTS  
A total of 71 patients were eligible for inclusion in the study. One patient was excluded because he 
received a steroid pulse before admission and 15 patients were excluded because the amount of 
saliva samples was insufficient for the assay (Figure 1).  
Baseline characteristics of the 55 evaluated patients are reported in Table 1.  
 
 
Table 1. Baseline features of the overall samples and the two groups classified according to 
presence of sepsis. 
Characteristics 
Overall 
(n=55) 
Sepsis  
(n=22) 
No Sepsis 
(n=33) 
p 
Gender – N. (%) 
Male 
Female 
36 (65%) 
19 (35%) 
14 (63.6%) 
8 (36.4%) 
22 (66.7%) 
11 (33.3%) 
 
0.86 
Age at admission – yr 
Median [range] 70 [17-87] 65 [42-87] 71 [17-84] 
 
0.49 
BMI – kg/m2 
Median  
[range] 
 
26.8 
[16.3-48.9] 
 
26.0 
[16.3-46.8] 
 
27.5 
[18.5-48.9] 
 
0.10 
Systolic Blood Pressure – 
(mmHg) 
Median [range] 
 
130 [70-230] 
 
125 [70-230] 
 
136 [87-230] 
 
0.07 
Diastolic Blood Pressure – 
(mmHg) 
Median [range] 
 
70 [35-130] 
 
70 [40-130] 
 
70 [35-120] 
 
0.47 
Heart rate – (bpm) 
Median [range] 
 
90 [65-160] 
 
99 [70-130] 
 
86 [65-160] 
 
0.32 
Respiratory rate – (bpm) 
Median [range] 
 
26 [12-46] 
 
24 [12-46] 
 
27 [14-44] 
 
0.93 
SO2 – (%) 
Median [range] 
 
94 [70-99] 
 
96 [70-99] 
 
94 [72-99] 
 
0.91 
Temperature – (°C) 
Median [range] 
 
37 [36-41] 
 
37.4 [36-41] 
 
37 [36-39] 
 
0.01 
Lactate – (mmol/L) 
Median [range] 
 
1.4 [0.1-8.3] 
 
1.5 [0.5-7.7] 
 
1.4 [0.1-8.3] 
 
0.80 
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Protein - (g/dL) 
Median [range] 6.1 [4.3-7.9] 5.5 [4.3-7.8] 6.3 [5.5-7.1] 
 
0.02 
Albumin – (g/dL) 
Median [range] 3.1 [0.5-4.3] 2.8 [1.5-4.3] 3.4 [0.5-4.3] 
 
0.02 
Hospitalization – (day) 
Median [range] 
 
11 [4-38] 
 
11 [4-24] 
 
10.5 [4-38] 
 
0.73 
Hospitalization in ED– (day) 
Median [range] 
6 [1-21] 6 [2-15] 5 [1-10] 
 
 
0.76 
 
BMI=body mass index; SBP=systolic blood pressure; DBP=diastolic blood pressure; SO2=hemoglobin oxygen saturation. 
 
The patient group had different medical emergencies; the most frequent diagnosis at presentation 
was acute respiratory failure (50.9%) followed by acute heart failure (16.4%), suspected infections 
(16.4%), trauma (7.3%), acute pancreatitis (3.6%), septic shock (3.6%), or any organ failure (1.8%). 
A broad spectrum of comorbidities affected our patients, such as arterial hypertension (56.4%), 
diabetes mellitus (30.9%), coronary artery disease (25.4%), heart failure (21.8%), chronic kidney 
disease (20%), chronic obstructive pulmonary disease (20%), arrhythmia (14.5%), vascular disease 
(7.3%), liver disease (3.6%), pulmonary hypertension (3.6%), peripheral arterial disease (1.8%), 
peptic ulcer (1.8%), autoimmune diseases (1.8%). We divided our population in two subgroups 
based on the presence of sepsis, which was diagnosed in 22 out of 55 patients. Baseline 
characteristics of the two subgroups of patients are reported in Table 1.  
In the overall sample, the median SAPS II score was 37 (16-77), without difference between the 
two groups (sepsis group, 36, 16-61 vs. no-sepsis group, 37, 17-77, p = 0.76). In the sepsis group, 
the median qSOFA was 1 [range 0-2]. 
Median serum cortisol concentration at T0 in the overall sample was 819 nmol/L (292-2458 
nmol/L) and median salivary cortisol concentration at T0 was 41 nmol/L (range 1-347 nmol/L). No 
patient had baseline serum cortisol < 276 nmol/L. Median serum cortisol concentration at T48 was 
634 nmol/L (287-1826 nmol/L) and median salivary cortisol concentration at T48 was 13 nmol/L 
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(range 1-253 nmol/L). We found a significant correlation between serum and salivary cortisol 
concentrations measured at T0 (r 0.84, p <0.001), and T48 (r 0.81, p <0.001).  
We found a statistically significant difference between salivary cortisol concentrations at T0 vs. T48 
(p<0.001) (Figure 2).  
In the sepsis group, salivary cortisol concentration decreased from 60 nmol/L (range 1-347 nmol/L) 
at T0 to 21 nmol/L (1-135 nmol/L) at T48 (p<0.001). In the no-sepsis group, salivary cortisol 
concentration decreased from 39 nmol/L (range 1-221 nmol/L) at T0 to 11 nmol (range 1-253 
nmol/L) at T48 (p=0.022) (Figure 3). We also compared salivary cortisol concentrations between 
the two groups and we found a statistically significant difference in salivary cortisol values at T48 
(p=0.03), while no significant difference was apparent at T0 (Figure 3). 
We did not find any significant correlation between serum or salivary cortisol and SAPS values. 
For logistic reasons (i.e. night-time admission), the ACTH stimulation test was performed in 33 
patients. The serum cortisol value at 60 min was 1534 nmol/L (510-2676 nmol/L), and the salivary 
cortisol was 156 nmol/L (range 17-1528 nmol/L); with a significant correlation between them (r 
0.49, p <0.01). The delta serum cortisol was 588 nmol/L (range -110 – 1432 nmol/L) and the 
percentage of the increase was 79% (range -6 – 393%). The delta salivary cortisol was 113 nmol/L 
(range -54 – 1308 nmol/L) and the percentage of the increase was 191% (range -16 –1672%) 
(Figure 4).  
We found a delta serum cortisol < 250 nmol/L in 4 out 33 cases (12.1%). These patients had 
exceedingly high serum cortisol levels at T0 (1581; 1545; 2458; 1975 nmol/L, respectively), high 
values of SAPS (39, 58, 61, 77, respectively), increased lactate concentrations, and sepsis was 
diagnosed in three of them. The response of salivary cortisol to Synacthen was also blunted (percent 
of increment 37%, -7%, -16%, 18%, respectively). 
Mortality rate was 1/55 patients at T48, and 5/55 patients at day 28. Due to the low mortality rate 
observed in our cohort, we did not analyze the correlation with cortisol levels.  
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DISCUSSION 
In the last 30 years, there was a fierce debate on the existence of a correlation between mortality 
and cortisol levels in critically ill patients, particularly when levels are at the lower end of the 
spectrum, configuring the so-called CIRCI [2,4,5]
 
, or when they are exceedingly high [6,7,8]. In 
both cases, the assessment of serum cortisol is not completely reliable, due to the decrease of CBG 
and albumin in critically ill patients [17]. As a matter of fact, 80-90% of serum cortisol is bound to 
CBG, 5-10% is bound to albumin, while only 5% is unbound [18]. At the same time, the laboratory 
evaluation of free serum cortisol is difficult, requiring special equipment. On the contrary, salivary 
cortisol measurement is cheap, noninvasive and unaffected by variations in CBG or albumin. 
The recent guidelines on CIRCI diagnosis and management suggest against the use of salivary 
cortisol for diagnostic purposes, although this is a conditional recommendation with a very low 
quality of evidence [5]. One of the objections raised in the guidelines concerns the difficulty in 
collecting adequate salivary samples in critically ill patients, often intubated and dehydrated. 
Studies report that it was impossible to analyze about 30% of the salivary samples, due to 
insufficient saliva, or blood contamination [13,14]; conversely, in one study [12] only 5.5% of 
enrolled patients had inadequate saliva samples. In the present study, we confirm that collecting 
saliva is not an easy task in the ER, since 21.4% of our patients were excluded due to a small 
volume of saliva collected. This discrepancy among the studies is probably due to different types of 
population analyzed, with variable grade of illness severity and number of intubated patients. 
Whether the use of different saliva-collecting devices (for example infant-swab-devices) could 
ameliorate the success of obtaining adequate saliva samples in critically ill patients deserves future 
investigation. 
Many studies supported the use of salivary cortisol as a surrogate for free cortisol in patients with 
critical illness, because it is as reliable as serum free cortisol, but not affected by the high cost and 
low availability of equilibrium dialysis, needed to determine free serum cortisol [12,13,14].  
This concept was confirmed by our study, where we found a significant correlation between serum 
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and salivary cortisol measurements. The strong correlation between salivary cortisol and total serum 
cortisol levels has been demonstrated not only at baseline, as in previous studies [12,13,14] but also 
after 48 hours of hospitalization.  This is a new element introduced by our research reporting a 
statistically significant difference between T0 and T48 salivary cortisol concentrations in the whole 
group, and in the two subgroups of septic and non-septic patients. We showed that salivary cortisol 
decreases after 48 hours, a finding that likely reflects the shutting down of adrenal hyperactivity. 
Interestingly, the change in salivary cortisol seems to be more sensitive and precocious that serum 
cortisol, which was less modified over time. We observed a similar pattern during ACTH 
stimulation test. There are scanty data on the response of salivary cortisol to Synacthen and a 
universally accepted cut-off is not available [12, 19, 20], due to the great heterogeneity of the assays 
used to measure salivary cortisol between different studies.  
This is the first study with a direct comparison between septic and non-septic patients, classified on 
the basis of the recent diagnostic criteria of sepsis [16].  In our study, we did not find any 
correlation between the severity of illness and salivary or serum cortisol levels. Therefore, our data 
do not seem to support the hypothesis that salivary cortisol increases in parallel to the severity of 
stress [13]. However, we may disclose the fact that the severity of illness and sepsis was moderate 
in many patients. Moreover, we found a significantly higher value of salivary cortisol at T48 in the 
group of septic patients, which may reflect a more persistent activation of the HPA axis in this 
condition. We also found a correlation between serum and salivary cortisol at 60 min of the ACTH 
stimulation test. The role of salivary cortisol as surrogate for serum free cortisol in dynamic testing 
of adrenocortical function has been previously investigated [12, 19, 20], and our findings further 
support the use of salivary cortisol in this setting. 
We did not find any evidence of CIRCI in our cohort, since no patient had baseline serum cortisol 
<276 nmol/L, and a delta serum cortisol < 250 nmol/L after ACTH stimulation was observed in 
only 12% of cases. However, baseline cortisol levels were very high in such patients, suggesting 
that the reduced delta cortisol value may reflect a maximally stimulated HPA axis more than 
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adrenal insufficiency. Interestingly, the 4 patients with a delta serum cortisol < 250 nmol/L after 
ACTH stimulation had concomitantly blunted salivary cortisol response. 
We acknowledge the limitations of the study, including a small sample size and the heterogeneity of 
the population. Moreover, it could be argued that the low severity of illness in our patients, 
confirmed by a low mortality rate, is also a limitation.  
To conclude, proven that patients are able to collaborate and provide adequate saliva samples, 
salivary cortisol may be used to check the degree of stress-induced activation of the HPA axis, and 
appears as a suitable tool for multiple measurements over time.  
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Figure 1. Study cohort. 
 
  
 
 
Figure 2. Salivary (2a) and serum (2b) cortisol concentration in the overall sample at T0 and T48. 
The box identifies 25-75% range and the whisker the non-outlier range. 
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Figure 3.  Salivary (3a) and serum (3b) cortisol concentration at T0 and T48, in sepsis and no sepsis 
group.  
The box identifies the 25-75% range and the whisker the non-outlier range. 
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Figure 4. Salivary (4a) and serum cortisol (4b) before and after ACTH stimulation test.  
The box identifies the 25-75% range and the whisker the non-outlier range. 
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HIGHLIGHTS 
 
 The usefulness of salivary cortisol to study stress-related adrenal response is still debated.  
 Fifty-five critically ill patients were studied at baseline (T0) and after 48 hours (T48).  
 A significant correlation between serum and salivary cortisol at T0 and T48 was found. 
 Salivary cortisol decreases at T48, reflecting the shutting down of adrenal hyperactivity.  
 Salivary cortisol appears a suitable tool for multiple measurements over time. 
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